Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rigel Capital Management is an active Singapore-based venture capital investment firm established in 2022. It focuses on providing growth capital to hyper-growth companies in emerging economies of Southeast Asia, India, and the Middle East. The firm's portfolio spans logistics, food security, retail, trade, sustainable mobility, and includes investments in biotechnology and transportation. It has made nine investments with eight active portfolio companies and one exit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rigel Capital Management.